Modern Diagnostics and Therapy for Vitreoretinal Diseases
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 75
Special Issue Editors
2. EyeCare Partners, St. Louis, MO, USA
Interests: ophthalmology; retinal disease; retinal pharmacotherapy; artificial intelligence; retinal diagnostic imaging
Interests: ophthalmology; retina; retinal imaging; diabetic retinopathy; surgical retina; cell therapy
Special Issue Information
Dear Colleagues,
Therapies for vitreoretinal diseases have grown by leaps and bounds over the last five years. Longer-acting agents for the treatment of exudative disease and a plethora of available and experimental therapies for geographic atrophy now abound. Simultaneously, the diagnostic platforms to help evaluate retinal conditions continue to evolve.
Meanwhile, artificial intelligence (AI) and remote monitoring are becoming more prevalent in ophthalmic diagnostics. Image-recognition-based deep learning is allowing for large-scale data assessments related to ophthalmic testing and imaging. For example, this technology is proving to be useful in studying fluid dynamics in exudative retinal disease and for predictive modeling in non-exudative macular degeneration.
This Special Issue aims to bring together the current state of clinical and laboratory data regarding retinal diagnostics and therapies. Relevant topics should include but are not limited to pharmacotherapy, optical coherence tomography, remote retinal monitoring, artificial intelligence in retinal diagnostics, image recognition platforms, and surgical innovations.
Colleagues are invited to submit original research, meta-analyses, and topical reviews for the Special Issue “Modern Diagnostics and Therapies for Vitreoretinal Disease” to further our knowledge base in this important field.
Sincerely,
Dr. Miguel Antonio Busquets
Prof. Dr. Anat Lowenstein
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal pharmacotherapy
- artificial intelligence
- image recognition
- optical coherence tomography
- remote retinal monitoring
- exudative retinal disease
- geographic atrophy
